Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura

被引:6
作者
Picod, Adrien [1 ]
Coppo, Paul [1 ,2 ,3 ]
机构
[1] AP HP, Ctr Natl Reference MicroAngiopathies Thrombot, Paris, France
[2] Hop St Antoine, AP HP, Serv Hematol, Paris, France
[3] Sorbonne Univ, Paris, France
关键词
ADAMTS13; caplacizumab; plasma exchange; plasmapheresis; rituximab; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; von Willebrand factor; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; FRESH-FROZEN PLASMA; BLUE-PHOTOINACTIVATED PLASMA; THERAPEUTIC PLASMA; RECOMBINANT ADAMTS13; MICROANGIOPATHIES; RITUXIMAB; EXPERIENCE; MANAGEMENT;
D O I
10.1080/17474086.2019.1619170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening disease characterized by a severe functional deficit in the von-Willebrand cleaving protease ADAMTS13, due to autoantibody production. The once-dismal prognosis of the disease has been changed by the discovery of the dramatic efficiency of therapeutic plasma exchange (TPE). Areas covered: This review focuses on the history and recent developments in the use of TPE for iTTP with a special emphasis on the consequences for TPE practice of the recent introduction of new highly effective immunosuppressive strategies and anti-von Willebrand factor (vWF) therapies. Expert opinion: Although TPE still represents the cornerstone, emergency treatment of iTTP, their duration, and associated complications could be dramatically reduced in the future by the systematic addition of early immunosuppression using corticosteroids and rituximab as well as an anti-vWF therapy with caplacizumab.
引用
收藏
页码:461 / 471
页数:11
相关论文
共 102 条
[1]   Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura [J].
Alvarez-Larrán, A ;
Del Río, J ;
Ramírez, C ;
Albo, C ;
Peña, F ;
Campos, A ;
Cid, J ;
Muncunill, J ;
Sastre, JL ;
Sanz, C ;
Pereira, A .
VOX SANGUINIS, 2004, 86 (04) :246-251
[2]   Characterization and treatment of congenital thrombotic thrombocytopenic purpura [J].
Alwan, Ferras ;
Vendramin, Chiara ;
Liesner, Ri ;
Clark, Amanda ;
Lester, William ;
Dutt, Tina ;
Thomas, William ;
Gooding, Richard ;
Biss, Tina ;
Watson, H. G. ;
Cooper, Nichola ;
Rayment, Rachel ;
Cranfield, Tanya ;
van Veen, Joost J. ;
Hill, Quentin A. ;
Davis, Sarah ;
Motwani, Jayashree ;
Bhatnagar, Neha ;
Priddee, Nicole ;
David, Marianna ;
Crowley, Maeve P. ;
Alamelu, Jayanthi ;
Lyall, Hamish ;
Westwood, John-Paul ;
Thomas, Mari ;
Scully, Marie .
BLOOD, 2019, 133 (15) :1644-1651
[3]   THROMBOTIC THROMBOCYTOPENIC PURPURA - REPORT OF 16 CASES AND REVIEW OF LITERATURE [J].
AMOROSI, EL ;
ULTMANN, JE .
MEDICINE, 1966, 45 (02) :139-+
[4]   More on Ofatumumab for TTP [J].
Aubart, Fleur Cohen ;
Haroche, Julien ;
Amoura, Zahir .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (14) :1364-1365
[5]   High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study [J].
Balduini, Carlo L. ;
Gugliotta, Luigi ;
Luppi, Mario ;
Laurenti, Luca ;
Klersy, Catherine ;
Pieresca, Carla ;
Quintini, Gerlando ;
Iuliano, Francesco ;
Re, Rossana ;
Spedini, Pierangelo ;
Vianelli, Nicola ;
Zaccaria, Alfonso ;
Pogliani, Enrico Maria ;
Musso, Roberto ;
Pallavicini, Enrico Bobbio ;
Quarta, Giovanni ;
Galieni, Piero ;
Fragasso, Alberto ;
Casella, Gianluca ;
Noris, Patrizia ;
Ascari, Edoardo .
ANNALS OF HEMATOLOGY, 2010, 89 (06) :591-596
[6]   Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience [J].
Beloncle, Francois ;
Buffet, Marc ;
Coindre, Jean-Philippe ;
Munoz-Bongrand, Nicolas ;
Malot, Sandrine ;
Pene, Frederic ;
Mira, Jean-Paul ;
Galicier, Lionel ;
Guidet, Bertrand ;
Baudel, Jean-Luc ;
Subra, Jean-Francois ;
Tanguy-Schmidt, Aline ;
Pourrat, Jacques ;
Azoulay, Elie ;
Veyradier, Agnes ;
Coppo, Paul .
TRANSFUSION, 2012, 52 (11) :2436-2444
[7]   Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study [J].
Bendapudi, Pavan K. ;
Hurwitz, Shelley ;
Fry, Ashley ;
Marques, Marisa B. ;
Waldo, Stephen W. ;
Li, Ang ;
Sun, Lova ;
Upadhyay, Vivek ;
Hamdan, Ayad ;
Brunner, Andrew M. ;
Gansner, John M. ;
Viswanathan, Srinivas ;
Kaufman, Richard M. ;
Uhl, Lynne ;
Stowell, Christopher P. ;
Dzik, Walter H. ;
Makar, Robert S. .
LANCET HAEMATOLOGY, 2017, 4 (04) :E157-E164
[8]   Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center [J].
Benhamou, Y. ;
Boelle, P-Y ;
Baudin, B. ;
Ederhy, S. ;
Gras, J. ;
Galicier, L. ;
Azoulay, E. ;
Provot, F. ;
Maury, E. ;
Pene, F. ;
Mira, J. -P. ;
Wynckel, A. ;
Presne, C. ;
Poullin, P. ;
Halimi, J. -M. ;
Delmas, Y. ;
Kanouni, T. ;
Seguin, A. ;
Mousson, C. ;
Servais, A. ;
Bordessoule, D. ;
Perez, P. ;
Hamidou, M. ;
Cohen, A. ;
Veyradier, A. ;
Coppo, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (02) :293-302
[9]   Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience [J].
Benhamou, Ygal ;
Assie, Cyrielle ;
Boelle, Pierre-Yves ;
Buffet, Marc ;
Grillberger, Rana ;
Malot, Sandrine ;
Wynckel, Alain ;
Presne, Claire ;
Choukroun, Gabriel ;
Poullin, Pascale ;
Provot, Francois ;
Gruson, Didier ;
Hamidou, Mohamed ;
Bordessoule, Dominique ;
Pourrat, Jacques ;
Mira, Jean-Paul ;
Le Guern, Veronique ;
Pouteil-Noble, Claire ;
Daubin, Cedric ;
Vanhille, Philippe ;
Rondeau, Eric ;
Palcoux, Jean-Bernard ;
Mousson, Christiane ;
Vigneau, Cecile ;
Bonmarchand, Guy ;
Guidet, Bertrand ;
Galicier, Lionel ;
Azoulay, Elie ;
Rottensteiner, Hanspeter ;
Veyradier, Agnes ;
Coppo, Paul .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1181-1186
[10]  
BobbioPallavicini E, 1997, HAEMATOLOGICA, V82, P429